CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Jiangsu Hengrui Medicine Co., Ltd. Company Snapshot
Jiangsu Hengrui Medicine Co., Ltd. operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Jiangsu Hengrui Medicine Co., Ltd. with three other companies in this sector in China: Shanghai Shyndec Pharmaceutical Co Ltd (2016 sales of 9.12 billion Chinese Renmimbi [US$1.33 billion] of which 49% was Drug Products), China Resources Sanjiu Medical & Pharmaceutical Co Ltd (8.98 billion Chinese Renmimbi [US$1.30 billion] of which 95% was Pharmaceutical), and North China Pharmaceutical, Limited (8.08 billion Chinese Renmimbi [US$1.17 billion] of which 43% was Chemical Preparation Medicine).

Sales Analysis. During the year ended December of 2016, sales at Jiangsu Hengrui Medicine Co., Ltd. were 11.09 billion Chinese Renmimbi (US$1.61 billion). This is an increase of 19.1% versus 2015, when the company's sales were 9.32 billion Chinese Renmimbi. This was the fifth consecutive year of sales increases at Jiangsu Hengrui Medicine Co., Ltd. (and since 2011, sales have increased a total of 144%). Sales of Medicinal Manufacturing saw an increase of 21.2% in 2016, from 9.14 billion Chinese Renmimbi to 11.08 billion Chinese Renmimbi. Not all segments of Jiangsu Hengrui Medicine Co., Ltd. experienced an increase in sales in 2016: sales of Other Businesses fell 89.8% to 17.77 million Chinese Renmimbi. (However, this segment's sales were only a very small portion of the company's overall sales).
   
   
 
Company ReportsSubscriptions
 
Looking For More?
Purchace an In-Depth Report
Jiangsu Hengrui Medicine Co., Ltd.
  Stock Performance Chart for Jiangsu Hengrui Medicine Co., Ltd.
 
  Stock Data: Recent Stock Performance:
  Current Price (3/24/2017): 53.48
(Figures in Chinese Renmimbi)
1 Week 2.9%   13 Weeks 4.1%  
4 Weeks 18.0%   52 Weeks 35.4%  
 
Jiangsu Hengrui Medicine Co., Ltd. Key Data:
  Ticker: 600276 Country: China
  Exchanges: SHG Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 11,093,724,121
(Year Ending Jan 2017).
Employees: 12,653
  Currency: Chinese Renmimbi Market Cap: 125,308,538,554
  Fiscal Yr Ends: December Shares Outstanding: 2,343,091,596
  Share Type: A Gu Closely Held Shares: 1,342,711,824
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.